Skip to main content
Clinical Trials/NCT02535624
NCT02535624CompletedNot Applicable

Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures - Quasi-randomized Clinical Trial of 56 Hemodynamically Unstable Patients With Injury Severity Score ≥ 33

Uppsala University1 site in 1 country56 target enrollmentStarted: February 1, 2003Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
56
Locations
1
Primary Endpoint
Number of participants deceased occurring in-hospital during or after treatment with packing or embolization

Study Overview

Brief Summary

This study is designed to answer whether minimal invasive vessel clotting (angioembolization) or open surgery (retroperitoneal packing) is more effective for pelvic fractures with massive bleeding. Patients admitted at daytime (7am-5pm) are treated with angioembolization while patients admitted at nighttime (5pm to 7am) are treated with open surgery.

Detailed Description

In patients with pelvic fracture uncontrollable bleeding is the major cause of death within the first 24h after injury. Early hemorrhage control is therefore vital for successful treatment. Nowadays, recommended techniques for hemorrhage control in pelvic fractures are retroperitoneal pelvic packing and angioembolization, dependent upon the available technical staff and resources and the condition of the patient.

Retroperitoneal pelvic packing, on the one hand, is a relatively simple method in controlling pelvic hemorrhage even with limited resources. Since 89% of pelvic fracture hemorrhage originates from venous bleeding, fracture stabilization and compressive hemostasis by packing is a reasonable approach. Angioembolization, on the other hand, has great high effectiveness with regard to bleeding control, but requires an angiography suite and technical staff. Since hemostasis of retroperitoneal venous bleeding often can be achieved by external pelvic fixation, angioembolization is required for the 11% arterial bleedings which are hard to control by packing. Even though many authors see both methods as complements, time is crucial in the multitrauma setting and the severely injured patient does not tolerate multiple interventions well. Until now good predictors for treatment choice are unavailable, and management of hemodynamically unstable pelvic fractures remains a matter of debate.

This study was designed to answer following questions:

  • Is retroperitoneal pelvic packing or angiography superior with regard to in-hospital mortality, complications, required secondary procedures, or post-intervention blood loss?
  • Which of these methods is the more rapid intervention in the acute setting?

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •multitrauma defined as Injury Severity Score (ISS) > 17
  • •dislocated pelvic fracture type B or C according to Tile[10] on emergency department pelvic radiograph
  • •hemodynamic instability defined as systolic blood pressure (SBP) <90 mmHg after administration of 4 units of packed red blood cells (PRBC).

Exclusion Criteria

  • •monotrauma, or ISS ≤ 17
  • •age > 65 years
  • •age < 18 years

Arms & Interventions

ANGIO

Active Comparator

Patients with persistent hemodynamic instability (systolic blood pressure (SBP) <90 mmHg after the transfusion of 4 packed red blood cell (PRBC) units in the emergency department) were taken urgently to the angiography suite for pelvic angiography. These patients had to tolerate transfer to the suite. Patients receiving primarily angioembolization therapy were defined as the ANGIO group.

Intervention: ANGIO (Procedure)

PACKING

Active Comparator

Indication for pelvic packing was persistent SBP<90 mmHg during the initial resuscitation period with 3000 ml of intravenous (IV) crystalloids and transfusion of 4 PRBC units. These patients were treated primarly with retroperitoneal packing, while angioembolization OR staff was unavailable (5pm-7am), and were defined as the PACK group.

Intervention: PACKING (Procedure)

Outcomes

Primary Outcomes

Number of participants deceased occurring in-hospital during or after treatment with packing or embolization

Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks

Secondary Outcomes

  • Time from admission (in minutes) to treatment (PACKING or ANGIO) for each participant(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Number of participants which required a secondary procedure (PACKING or ANGIO) after the primary intervention (PACKING or ANGIO)(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Days on ICU for each participant(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Number of postoperative packed red blood cell units administered for each participant(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)
  • Procedural/surgical time (in minutes) for each participant(participants will be followed for the duration of hospital stay, an expected average of 6 weeks)

Investigators

Sponsor
Uppsala University
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials